Regulatory-Compliant Business Sale Agreement

Outstanding liabilities are typically managed by explicitly categorizing them as either assumed liabilities or excluded liabilities within the agreement. The seller remains responsible for excluded liabilities, while the buyer takes on assumed liabilities, backed by indemnification clauses to secure compliance. Escrow accounts are frequently established to hold back a portion of the purchase price to cover any undisclosed pre-closing liabilities.

Purchase price allocation divides the total acquisition cost among the acquired assets, such as goodwill, equipment, and real estate, for tax reporting. This allocation directly impacts the depreciation deductions for the buyer and the capital gains tax liability for the seller. Both parties must agree on this allocation to file identical IRS Form 8594 disclosures.

To be legally enforceable, restrictive covenants must be reasonable in geographic scope, duration, and the definition of prohibited business activities. Courts routinely strike down clauses that are overly broad or restrict a seller’s ability to earn a living outside of the specific competitive market. The agreement should tailor these covenants precisely to the legitimate business interests being protected by the buyer.

The agreement must include a conditions precedent section that outlines the consequences of failing to secure mandatory regulatory approvals. If a required regulatory body denies the transfer or license, the contract typically allows either party to terminate the agreement without penalty. It also details how earnest money deposits or transition costs are distributed in the event of such a termination.